Khachaturian Radebaugh and Associates, Inc. (KRA) is an international consulting group on Alzheimer’s disease and aging. KRA provides a wide range of services associated with planning, developing, and managing science and technology based programs. The group has extensive experience in evaluating scientific opportunities, translating technical information, and designing efficient administrative systems for complex programs. The company’s core competencies are building scientific bridges and creating interfaces for establishing collaborative programs with diverse disciplines. KRA serves a spectrum of science and technology related needs for the pharmaceutical and biotechnology industries, academia, governments, foundations, private voluntary health organizations and investment groups.